Novigenix
17.1.2024 08:02:15 CET | ACCESS Newswire | Press release
GENEVA, SWITZERLAND / ACCESSWIRE / January 17, 2024 / With cancer projected to escalate to 29 million cases by 2040[1], Novigenix, a pioneer in AI healthcare solutions, is rewriting the rules of cancer care. Their newest innovation, LITOSeek™, is primed to reshape drug development, offering a transformative leap forward.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.Personalized Cancer Treatment: Breaking Barriers
Every cancer is as unique as the person it affects. Tumors are in continuous dynamic interplay with the patient's immune defenses and are adept at subverting and escaping immune control. Novigenix is on a mission to improve the cancer treatment landscape, leveraging advanced AI and RNA analysis from a routine blood draw to provide more precise insights into patient immune responses to cancer treatments, compared to conventional DNA liquid biopsies that evaluate tumor evolution through circulating tumor DNA (ctDNA). Insights into the precise dynamic of patient immune response thus pave the way for superior therapeutic discoveries in the field.
Empowering Biopharma: Unveiling LITOSeek™ at Precision Medicine World Conference
On January 24th at the Precision Medicine World Conference in Silicon Valley, Novigenix will debut LITOSeek™, a groundbreaking solution designed to expedite drug development for biopharma companies.
AI and RNA Analysis: Pioneering Healthcare Transformation
With a decade-long track record, Novigenix successfully launched Colox® blood test in Switzerland, powered by AI and RNA analysis to detect early-stage colon cancer, marking a significant departure from invasive colonoscopy procedures. By aggregating data from diverse colon cancer patients, Novigenix identified immune system biomarkers crucial for early-stage detection, enhancing treatment outcomes.
Dr. Brian Hashemi, Novigenix's CEO and Chairman, emphasized, "Our experience with Colox® underscores the potential of AI RNA analysis. Ongoing studies across various cancer types have fuelled our Knowledge Base to uncover comprehensive sets of biomarkers via liquid biopsy and AI RNA analysis. Our validated immunotherapy response biomarkers provide early prediction of patient response and we invite biopharma companies to leverage our platform for more efficient and effective drug development."
Professor Pedro Romero, M.D. Chief Medical & Scientific Officer of Novigenix, and Founding Chief Editor of the Journal of Immunotherapy of Cancer, highlights the importance of patient immune response in the development of novel therapies: "AI RNA analysis is poised to revolutionize healthcare, accelerating conventional experimental drug development with data-driven precision immune response prediction. By swiftly analyzing systemic immune responses, AI compresses analysis times, expediting traditional drug development and powering discovery of novel therapy targets."
A Team Dedicated to the Future of Cancer Care
With over 20 Ph.D.-level scientists focused on the development of the LITOSeek™ platform and advancing next-generation liquid biopsy solutions, Novigenix is pioneering precision immunology to help transform cancer treatment paradigms for better patient outcomes.
#Ends#
[1] https://canceratlas.cancer.org/the-burden/the-burden-of-cancer/
Contact Information
Edwin Shankar
edwin.shankar@leidar.com
SOURCE: Novigenix
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
U.S. Mined and Refined Metals as well as Rare Earth Elements to Be Tokenized in Historic American Strategic Minerals and Datavault AI Deal26.3.2026 11:07:00 CET | Press release
Partnership Sets the Stage for the Launch of an International Elements Exchange Powered by Patented AI Platform Datavault AI and American Strategic Minerals debut minting of up to $2 billion USD of refined Antimony-backed stable coins will be followed by the strategic development of future projects in silver, gold, and other American refined Rare Earth Elements the companies have targeted for expansion PHILADELPHIA, PA AND LAS VEGAS, NV / ACCESS Newswire / March 26, 2026 / Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a provider of data monetization, credentialing, digital engagement, and real-world asset ("RWA") tokenization technologies, and American Strategic Minerals Inc. ("ASMI"), today announced a strategic partnership to develop and monetize one of ASMI's resource extraction projects in Arizona through a $78.2 million digital tokenization initiative, with Datavault AI entitled to earn up to a 20% equity interest in ASMI upon successful completion of performa
Stagwell Expands the Harris Poll's Harrisquest Across Europe26.3.2026 11:00:00 CET | Press release
Expanding always-on brand and reputation tracking with deeper consumer insights across Europe LONDON, GB / ACCESS Newswire / March 26, 2026 / Stagwell (NASDAQ:STGW), the global challenger network transforming marketing through AI, today announced the European expansion of The Harris Poll's HarrisQuest, bringing deeper always-on, brand and reputation tracking capabilities to Europe. This expansion brings HarrisQuest's trusted brand intelligence to Europe, extending capabilities already relied on by global companies like Lucid Motors, Storck, and Post Consumer Brands to inform critical brand decisions. Now, European brands and teams can access the same high-quality data, flexible and customizable platform, and global scale spanning 24 countries to guide strategy with greater speed and confidence. Built by researchers for enterprise growth, HarrisQuest delivers continuous, decision-ready insight designed to support modern brand decision-making. The platform uniquely combines brand health
Formerra Announces Transportation Surcharge to Address Ongoing Freight and Logistics Market Pressures25.3.2026 21:00:00 CET | Press release
CLEVELAND, OH / ACCESS Newswire / March 25, 2026 / Formerra, a leader in performance materials distribution, announced the implementation of a transportation surcharge to address continued cost escalation across the Americas freight and logistics market. Beginning April 1, 2026, a $350 per delivery surcharge will apply to all shipments. The freight and logistics market continues to experience elevated costs driven by rising diesel prices, evolving regulatory requirements affecting driver availability, tighter trucking capacity, and increasing operating expenses across the logistics sector. Industry forecasts indicate these pressures will persist for the foreseeable future. "Maintaining reliable service for our customers requires us to adapt to sustained shifts in the transportation landscape," said Tom Kelly, Formerra CEO. "This surcharge is necessary to address these industrywide cost pressures that are outside of our control while continuing to provide the high service levels custome
Vehicle Tech Week Europe announces Strategic Partnerships with PAVE Europe, ASAM and FISITA, Strengthening its Position as the Global Meeting Point for Future Vehicle Innovation25.3.2026 17:15:00 CET | Press release
STUTTGART, DE / ACCESS Newswire / March 25, 2026 / UKi Media & Events, the organizer of Vehicle Tech Week Europe today announced new strategic partnerships with PAVE Europe (Partners for Automated Vehicle Education), ASAM (Association for Standardization of Automation and Measuring Systems) and FISITA (Fédération Internationale des Sociétés d'Ingénieurs des Techniques de l'Automobile). These alliances reinforce the event's role as a key global hub for the technologies shaping the next era of vehicle mobility. Launching in Stuttgart, Germany, June 23-25, 2026, Vehicle Tech Week Europe brings together three of UKi Media & Events' leading shows - Automotive Testing Expo, Autonomous Vehicle Tech Expo, and Automotive Interiors Expo - into one integrated platform designed to meet the needs of an increasingly convergent industry. Partnerships that broaden expertise and industry alignment PAVE Europe, ASAM and FISITA bring deep experience across engineering, automation, safety, simulation, tes
Lithium Measurement MR-Technology Provider NanoNord Expands Business with DLE Leader ElectraLith, Following Danish State Visit to Australia25.3.2026 13:30:00 CET | Press release
Danish company expands collaboration with Australian deeptech rising star during the Royal State Visit to Melbourne AALBORG, DENMARK AND MELBOURNE, AU / ACCESS Newswire / March 25, 2026 / The North Jutland technology company NanoNord has, in connection with the Royal Couple's state visit to Australia, secured an order for additional measurement equipment valued at between 160k - 240k AUD from the Australian deeptech pioneer ElectraLith. The order underscores the growing international potential for Danish measurement technology in the green transition. NanoNord was part of the business delegation during the state visit and seized the opportunity to strengthen its business with both existing and new customers in Australia. It is not the first time the Danish Royal Family has been close to NanoNord - the company was originally officially inaugurated by a then-young Crown Prince Frederik. Danish Technology Measures Lithium in Real Time NanoNord's flagship technology, Tveskaeg, is an MR-bas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom